Effect of intravenous dexamethasone on blood sugar in patients undergoing gynecology surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201309192963N16

Enrollment

Registered

2013-10-07

Start date

2013-06-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus. Diabetes mellitus

Interventions

Intervention 1: 8 mg IV dexametasone to Intervention group. Intervention 2: in the control group normal salin infused.

Treatment - Drugs

8 mg IV dexametasone to Intervention group

in the control group normal salin infused

Eligibility

Sex/Gender

Female

Age

25 Years to 40 Years

Inclusion criteria

Inclusion criteria: include:all diabetic patients undergoing gynecology surgery exclude: history of corticostiroid use; blood sugar>200 on surgery day morning

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood sugar. Timepoint: 1,2,3,4,5,6 hours after surgery. Method of measurement: by glucometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shekoufeh Behdad

Shahid Sadoughi University of medical sciences

drbehdad@ssu.ac.ir+98 35 1822 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026